je.st
news
Tag: billion
Australia NBN cost grows by A$15 billion
2015-08-24 02:00:00| Total Telecom industry news
Next-gen broadband network company aims to cover 9.1 million homes in three years, but project will cost more than it previously stated.
Tags: cost
australia
billion
grows
Navigant expects global market for automotive Li-ion batteries to hit $30.6 billion in 2024; almost 4x 2015 market
2015-08-24 00:55:36| Green Car Congress
Tags: market
global
hit
automotive
Global Food Traceability Market - a $19.70 Billion Opportunity, Reveals New Report
2015-08-21 20:04:34| Logistics - Topix.net
Due to Increasing awareness among the consumers, strict goverment role in the traceability process, product loyalty, certifications and standardizations are the factors driving the market growth, the global food traceability market is expected to grow at a compound annual growth rate of 12.28% and reach US$19.7 billion by 2022 from $7.8 billion in 2014. Increasing adoption of Warehouse Management Software , Cloud Computing, Quality Management Solutions, Enterprise Resource Planning are also adding up to the market growth.
Global Smart Packaging Market 2015 Is Expected to Reach $45.03 Billion by 2022
2015-08-21 19:31:46| Paper - Topix.net
The Global Smart Packaging market is accounted for $27.2 billion in 2014 and is expected to grow at a CAGR of 6.5% to reach $45.03 billion by 2022. The challenge of the market includes High R&D costs and lack of sustainable E-Packaging products.
Tags: market
global
expected
reach
Novartis buys remaining rights to GSK treatment in deal up to $1 billion
2015-08-21 09:12:45| Biotech - Topix.net
Swiss drugmaker Novartis said on Friday it had agreed to buy all remaining rights to Ofatumumab, which is being developed for relapsing remitting multiple sclerosis and other autoimmune indications, from Britain's GlaxoSmithKline. Basel-based Novartis will make an initial upfront payment of $300 million to GSK for the acquisition of the compound and a further $200 million payable following the start of a phase III study in MS by Novartis.
Tags: to
rights
treatment
deal
Sites : [351] [352] [353] [354] [355] [356] [357] [358] [359] [360] [361] [362] [363] [364] [365] [366] [367] [368] [369] [370] next »